Reaction Biology

Reaction Biology Corporation is an industry leader and innovator, focusing on assay services and protein production for early drug discovery. Founded in 2001, Reaction Biology offers a wide range of services, including robust biochemical, biophysical, electrophysiological, and cell-based assay technologies for high-throughput screening (HTS) and selectivity compound profiling. RBC covers a broad range of targets, encompassing over 1,000 different targets with a focus on kinases and epigenetic targets. They also provide related HTS assay reagents, including highly purified and well-characterized epigenetic proteins.